National laboratory inventories for wild poliovirus containment--Western Pacific region, 2008

    Insights

    Global efforts to contain wild poliovirus (WPV) involve surveying facilities holding WPV materials. The Western Pacific Region completed Phase I containment, identifying 45 laboratories with WPV, crucial for preventing future outbreaks.

    Area of Science:

    • Public Health
    • Virology
    • Biosafety

    Background:

    • Wild poliovirus (WPV) containment is critical post-eradication to prevent reintroduction from remaining repositories.
    • The World Health Assembly (WHA) has urged member states to implement laboratory containment of WPV since 1999.
    • The World Health Organization (WHO) developed a phased action plan for global poliovirus containment, starting with Phase I surveys.

    Purpose of the Study:

    • To report the completion of Phase I laboratory containment activities in the WHO Western Pacific Region (WPR).
    • To update on global progress and previous findings in the European Region regarding WPV containment.
    • To provide a database of facilities holding WPV materials for subsequent containment steps.

    Main Methods:

    • Conducted Phase I surveys of 77,260 laboratories across 37 countries and areas in the WPR between 1999 and 2008.
    • Identified and inventoried institutions and facilities possessing WPV materials.
    • Alerted institutions to containment needs and encouraged reduction of WPV stocks.

    Main Results:

    • Phase I containment activities were completed by WPR countries.
    • A total of 45 laboratories in the WPR were identified as holding WPV materials as of 2008.
    • This survey established a crucial database for ongoing global poliovirus containment efforts.

    Conclusions:

    • The Western Pacific Region has successfully completed the initial phase of laboratory containment for wild poliovirus.
    • The identification of 45 WPV-holding laboratories is a key step towards minimizing risks associated with WPV repositories.
    • Continued progress in Phase I completion globally is essential for achieving ultimate poliovirus containment.